-       Enabling rapid site start-up with efficiencies gained by central process management including budgeting and contracting

            Proof point: Typical timelines for EMEA – 2 weeks and US – 3 weeks

• Delivering more patients per site using a finely tuned site feasibility approach.
  • A dedicated patient engagement team drive the identification and recruitment of suitable patients using EMR (in specific countries), an extensive database of pre-consented patients and targeted campaigns on digital channels. 
  • A healthcare partnership team connect with general practitioners to drive new patient referrals to our well established clinical research site network.

Proof point: XX patients per site in the last 6 months

• Ensuring quality and compliant services with the deployment of consistent processes, operating guidelines and tools across all sites.
• Proof point: 13 FDA Audits over 5 years with no findings, MHRA inspections in 2018 & 2019 with 1 major finding and no critical findings